Webinar

Clinical potential of CDK4/6 inhibitors in breast cancer (Part 1)

Click on the Chapters icon in the video toolbar to navigate through the sections of the video

Date of original release: 1 March 2024
Date credits expire: 1 March 2025

This webinar has been supported by an independent educational grant from Eli Lilly. Eli Lilly has had no influence over the content or selection of the Editorial Panel.

ACCREDITATIONS:

John Wiley & Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Wiley designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM per e-learning. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

CONFIRM